Phase I/II Study of Metastatic Melanoma Patients Treated with Nivolumab Who Had Progressed after Ipilimumab

Overview of attention for article published in Cancer Immunology Research, March 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (88th percentile)
Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

news: 1 news outlet
twitter: 1 X user

patent: 13 patents

Citations

dimensions_citation: 218 Dimensions

Readers on

mendeley: 164 Mendeley

Summary News X Patents Dimensions citations

So far, Altmetric has seen 13 patents that reference this research output.

Metal salts and uses thereof

Grant US-11878956-B2

United States of America

23 Jan 2024

Treatment and diagnosis of melanoma

Grant US-11865094-B2

United States of America

09 Jan 2024

Metal salts and uses thereof

Grant US-11459292-B2

United States of America

04 Oct 2022

Polymorphs and uses thereof

Grant US-11214536-B2

United States of America

04 Jan 2022

Metal salts and uses thereof

Grant US-11174220-B2

United States of America

16 Nov 2021

Treatment and diagnosis of melanoma

Grant US-10945978-B2

United States of America

16 Mar 2021

LXR agonists and uses thereof

Grant US-10669296-B2

United States of America

02 Jun 2020

Treatment and diagnosis of melanoma

Application US-10543183-B2

United States of America

28 Jan 2020

Treatment and diagnosis of melanoma

Grant US-9962348-B2

United States of America

08 May 2018

METHODS AND KITS FOR PREDICTING THE SENSITIVITY OF A SUBJECT TO IMMUNOTHERAPY

Application WO-2017140826-A1

World Intellectual Property Organisation (WIPO)

24 Aug 2017

Treatment and diagnosis of melanoma

Grant US-9707195-B2

United States of America

18 Jul 2017

Treatment and diagnosis of melanoma

Grant US-9526710-B2

United States of America

27 Dec 2016

Treatment of drug resistant cancer

Grant US-9399028-B2

United States of America

26 Jul 2016

American Association for Cancer Research

Article Metrics

Phase I/II Study of Metastatic Melanoma Patients Treated with Nivolumab Who Had Progressed after Ipilimumab

About this Attention Score

Mentioned by

Citations

Readers on

Metal salts and uses thereof

Grant US-11878956-B2

United States of America

Treatment and diagnosis of melanoma

Grant US-11865094-B2

United States of America

Metal salts and uses thereof

Grant US-11459292-B2

United States of America

Polymorphs and uses thereof

Grant US-11214536-B2

United States of America

Metal salts and uses thereof

Grant US-11174220-B2

United States of America

Treatment and diagnosis of melanoma

Grant US-10945978-B2

United States of America

LXR agonists and uses thereof

Grant US-10669296-B2

United States of America

Treatment and diagnosis of melanoma

Application US-10543183-B2

United States of America

Treatment and diagnosis of melanoma

Grant US-9962348-B2

United States of America

METHODS AND KITS FOR PREDICTING THE SENSITIVITY OF A SUBJECT TO IMMUNOTHERAPY

Application WO-2017140826-A1

World Intellectual Property Organisation (WIPO)

Treatment and diagnosis of melanoma

Grant US-9707195-B2

United States of America

Treatment and diagnosis of melanoma

Grant US-9526710-B2

United States of America

Treatment of drug resistant cancer

Grant US-9399028-B2

United States of America